EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comparison of Effectiveness of the Novel Periosteal Pedicle Graft Technique with Coronally Advanced Flap for the Treatment of Long‐Span Unesthetic Multiple Gingival Recession Defects

Ajay Mahajan, Kanwarjit Singh Asi

Clinical Advances in Periodontics · 2018

DOI: 10.1002/cap.10015 ↗
AbstractBibliografische Angaben

Abstract

Introduction Multiple gingival recession defects (MGRD) are considered a complex clinical scenario; therefore, recent scientific evidence suggests the need for further clinical research for treating MGRD. While coronally advanced flap (CAF) is an established procedure for the effective management of MGRD, its success is limited in terms of long‐term stability. The periosteal pedicle graft (PPG) has been drawing considerable attention as a treatment modality for managing gingival recession defects (GRD) owing to its immense regenerative potential and has shown promising results. Case Series Thirty‐five patients, with maxillary MGRD in the age group of 25 to 40 years were randomly divided into PPG (test) and CAF (control) groups. The percentage of root coverage along with mean change in probing depth (PD), gingival thickness (GT), width of keratinized gingiva (WKG) and width of attached gingiva (WAG) were recorded, at baseline and after 1 year. Patient satisfaction criteria were also compared, and the results were analyzed statistically. Conclusion After 1 year, the test group had 91.3% defect coverage while the control group had 76.3% defect coverage. PPG was more predictable than CAF in terms of percent root coverage with superior esthetic outcomes for the treatment of MGRD.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →